About
Oncorus is a clinical-stage biotechnology company developing oncolytic herpes simplex viruses for the treatment of cancer.
Explore Oncorus's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.
Oncorus is a clinical-stage biotechnology company developing oncolytic herpes simplex viruses for the treatment of cancer.
Funding rounds, investor list, and risk signals — unlock with a subscription.